Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accelerated Transcranial Magnetic Stimulation in Psychotic Disorders

NCT05567848 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT05567848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05567848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accelerated Transcranial Magnetic Stimulation in Psychotic Disorders
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Phase 1/2
Overall status
Suspended
Start date
November 29, 2022
Completion date
January 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prodromal schizophrenia, schizoaffective disorder, schizophrenia